Paresh
☆    

2011-03-25 10:02
(5575 d 04:40 ago)

Posting: # 6812
Views: 2,741
 

 Canada MR [Regulatives / Guidelines]

Hi,

is there need to calculate additional parameter AUCx and AUCx/AUCI for single dose study of Modified release product, for TPD (Canada) submission?


Edit: Subject line changed. [Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2011-03-25 14:27
(5575 d 00:15 ago)

@ Paresh
Posting: # 6813
Views: 2,409
 

 Canada MR: MD if accumulation likely

Dear Paresh!

❝ is there need to calculate additional parameter AUCx and AUCx/AUCI for single dose study of Modified release product, for TPD (Canada) submission?


Yes. See the Guideline. If the formulation is likely to accumulate with the intended dosage interval (AUCX/AUCI>0.8) additionally to single dose studies (Section 4.2) you have to perform multiple dose studies (Section 4.3). In order to make this decision, you have to know the value of AUCX/AUCI, right?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Paresh
☆    

2011-03-26 11:08
(5574 d 03:33 ago)

(edited on 2011-03-26 13:04)
@ Helmut
Posting: # 6816
Views: 2,240
 

 Canada MR: MD if accumulation likely

Hi,
Thank you for your valuable response.

For every MR product study need to calculate above mention parameters or decide from literature regarding accumulation of drug, than confirm from study.


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
291 visitors (0 registered, 291 guests [including 22 identified bots]).
Forum time: 15:42 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5